Year 2016 -

No data found
January 29, 2021

IPA Submission – USTR Special 301 Report

January 25, 2021

IPA Employee Safety Initiatives Report

August 20, 2021

Generic & biosimilar industry to focus on expanding reach through emerging and traditional modalities: Expert

August 20, 2021

IP Alliance, CSIR organize 1st Pharmaceutical Innovation Exchange Forum

August 18, 2021

‘Regulators should align to formulate standards for the approval of generic and biosimilar medicines – Sudarshan Jain’

August 17, 2021

COVID-19 and Beyond: Focusing on a Patient-centric Culture

August 15, 2021

Scripting independent India’s pharma industry journey from non-existent to a world leader

August 6, 2021

IGBA focusing to promote enabling regulatory environment for generic and biosimilar industry

July 27, 2021

Industry is ready to embrace Digitalization, Says IGBA

July 22, 2021

‘Everything cannot be locally produced,’ Says IGBA Chair

July 15, 2021

Manufacturing cooperation is key to equitable access of vaccines across countries: Dr. Rajesh Jain

July 7, 2021

IGBA launches whitepaper on global generic and biosimilar medicines industry

June 30, 2021

Global vaccination drive and current challenges

June 23, 2021

Strategic stockpiling of essential drugs a way forward for India to combat Covid-19

June 18, 2021

Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain

June 8, 2021

Difficult way to remove vaccine copyright

June 7, 2021

Covid-19 has unlocked new opportunities for the Indian pharma sector: Sudarshan Jain

June 6, 2021

Learning Never Stops

May 17, 2021

Covid-19 tests Indian pharma’s limits

May 7, 2021

Indian pharma cos welcome patent waivers on COVID vaccines, says tech transfer needed to scale up

May 6, 2021

China halting flights to India could hurt pharma supplies, say companies

April 29, 2021

IPA’s Jain Predicts 3-4 Weeks To Meet Indian Shortages

April 26, 2021

Future-ready supply chains

April 21, 2021

Remdesivir Crunch Is Due To Bad Science, Bad Politics: Ex-president, Indian Medical Association

April 14, 2021

Diverse and resilient supply chain significant for pharma industry: Experts

April 14, 2021

COVID-19 vaccines: India needs to rise

March 28, 2021

Patient-centricity must drive the pharma sector

March 25, 2021

PCI introduces faculty-industry training programme for teachers to make students industry-ready after graduation

March 22, 2021

Teachers should have good knowledge of drug development through exposure to industry practices: Expert

March 19, 2021

Dr Reddy’s On Digitization Amid COVID-19, ‘Lights-Out’ Manufacturing

March 18, 2021

Underlying the challenges and opportunities

March 1, 2021

Pharma stalwarts demystify COVID-19 impact on industry

February 25, 2021

Realisation there in pharma industry to become self-reliant in API production: IPA

February 22, 2021

India Pharmaceutical Forum to focus on patients, Covid-19

February 18, 2021

Pharma is a jewel in India’s crown with long term growth opportunities

January 28, 2021

Innovation and collaboration will help Indian pharma leapfrog in the global value chain: Experts

January 25, 2021

Back to Growth: Pharmaceutical sector overview and interview with Sudarshan Jain, Secretary General, IPA

January 24, 2021

Union Budget 2021: Covid-19 pandemic underlines need for higher allocation for healthcare sector

January 23, 2021

Industry opens bag of expectations for Union Budget 2021-22

January 20, 2021

Drug manufacturers hope new US govt will see them as ‘allies’

September 1, 2016

The United Nations Secretary-General’s High-Level Panel on Access to Medicines report- Promoting innovation…